Free Trial

20 Stocks Wall Street Analysts Love the Most - 3 of 20

→ 😱 This phenomenon is smashing regular market gains (From MillPub) (Ad)
Slide 3
Back to 2
Continue to 4
 
Back to 2
Continue to 4
 

Acuity Brands (NYSE:AYI)

Consensus Rating
Moderate Buy
Rating Score
2.5
Ratings Breakdown
2 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$289.25 (17.6% Upside)

About Acuity Brands

Acuity Brands logoAcuity Brands, Inc provides lighting, lighting controls, building management system, location-aware applications in the United States and internationally. The company operates in two segments, Acuity Brands Lighting and Lighting Controls (ABL); and the Intelligent Spaces Group (ISG). The ABL segment provides commercial, architectural, and specialty lighting solutions, as well as lighting controls and components for various indoor and outdoor applications under the A-Light, Aculux, American Electric Lighting, Cyclone, Dark to Light, eldoLED, Eureka, Gotham, Healthcare Lighting, Holophane, Hydrel, Indy, IOTA, Juno, Lithonia Lighting, Luminaire LED, Luminis, Mark Architectural Lighting, nLight, OPTOTRONIC, Peerless, RELOCWiring Solutions, and Sensor Switch. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/4/2024The Goldman Sachs GroupBoost Price TargetNeutral ➝ Neutral$227.00 ➝ $261.00
4/4/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$260.00 ➝ $295.00
4/4/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$250.00 ➝ $315.00
3/26/2024Robert W. BairdBoost Price TargetNeutral ➝ Neutral$236.00 ➝ $286.00
12/19/2023Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $236.00
10/5/2023Wells Fargo & CompanyBoost Price Target$180.00 ➝ $200.00
10/5/2023Robert W. BairdBoost Price Target$170.00 ➝ $180.00
9/21/2023Robert W. BairdLower Price TargetNeutral ➝ Neutral$175.00 ➝ $170.00
6/30/2023Robert W. BairdReiterated RatingNeutral ➝ Neutral$175.00
4/11/2023OppenheimerReiterated RatingOutperform$210.00
Slide 3
Back to 2
Continue to 4
 

Trump’s last act as President (Ad)

You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.

For the full story, click here.

More From MarketBeat
Have You Seen Elon’s New A.I. Device? (Picture Inside)
from InvestorPlace
15 Stocks Institutional Investors Are Selling Now
from MarketBeat
Biden to Launch “FedNOW” [Move Your Money Now]
from Priority Gold
7 Stocks Set to Boom from the Weight Loss Craze
from MarketBeat
A.I. is a Tidal Wave - Here’s What to Buy
from Chaikin Analytics
7 Stocks to Buy if Inflation Sticks Around in 2024
from MarketBeat